73 results
424B3
CRVO
CervoMed Inc
6 Jun 24
Prospectus supplement
6:03am
to execute;
delay or failure in obtaining authorization to commence a trial, including approval from the appropriate IRB or ethics committee at each … serious harm to the Company’s reputation. The Company has adopted a code of business conduct and ethics, but it is not always possible to identify and deter
8-K
EX-10.1
mvupj8g r725ov
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K/A
EX-99.2
bwnun
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.3
fgbn4p d3u
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
424B3
3xnzxl
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
atxv 8y7x
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
vqy0use
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
172cr953mzryhebt9af
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
ruo2a 3gr2gjvzenmgnh
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
DEFC14A
3xafwg4 hsitduh
5 Dec 22
Proxy in contested solicitation
5:12pm
PRER14A
3q0qqu87q uq5ebxdph
28 Nov 22
Preliminary revised proxy
5:17pm
PREC14A
h35refufsod3me wkb8
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm